VADUZ, Liechtenstein, Sept. 25, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop® for the treatment of acid reflux, a treatment […]
Tag: Implantica
Implantica announces U.S. FDA has provided feedback on the final RefluxStop® PMA submission, Module 3
VADUZ, Liechtenstein, Sept. 24, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop® for the treatment of acid reflux, a […]
Implantica’s RefluxStop® sparks strong excitement at the American Foregut Society meeting, ahead of pending US FDA approval
VADUZ, Liechtenstein, Sept. 17, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment […]
Implantica publishes Interim Report January
VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ — Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed – Submitted third and final module of the […]
Implantica finishes new multi-cavity production tool for RefluxStop® to support manufacturing ramp-up in the U.S. pending FDA approval
VADUZ, Liechtenstein, Aug. 13, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field […]
